公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1999 | Pharmacotherapy in Acute Spinal Cord Injury | WANG, YEN-HO; HUANG, TIEN-SHANG; 王顏和; 黃天祥 | Journal of Rehabilitation Medicine Association Republic of China | | | |
2012 | Pharmacotherapy of Osteoporosis | RONG-SEN YANG | Taiwan Geriatrics & Gerontology | | | |
2008 | Pharmacotherapy of post-transplant viral infections | HSIN-YUN SUN ; Singh N. | Expert Opinion on Pharmacotherapy | 4 | 2 | |
2018 | Pharyngeal airway changes following maxillary expansion or protraction: A meta-analysis | Lee W.-C.; YU-KANG TU ; Huang C.-S.; Chen R.; Fu M.-W.; Fu E. | Orthodontics and Craniofacial Research | 17 | 15 | |
2004 | Pharyngeal-brachial palsy after cytomegalovirus colitis | SUNG-TSANG HSIEH | Neurology | | | |
2004 | Pharyngeal-Brachial Palsy after Cytomegalovirus Colitis | PAN, CHUN-LIANG | NEUROLOGY | | | |
2004 | Pharyngeal-brachial palsy after cytomegalovirus colitis | CHUN-LIANG PAN ; CHIA-TUNG SHUN ; Susuki K.; Yuki N.; SUNG-TSANG HSIEH | Neurology | 3 | 1 | |
2004 | Pharyngeal-brachial palsy after cytomegalovirus colitis | CHIA-TUNG SHUN | Neurology | | | |
1986 | Phase Relationships of Gabbro Tonalite Granite Water at 15 Kb with Application to Differentiation and Anatexis | Huang, W. L.; Wyllie, P. J. | American Mineralogist | | | |
2014 | A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors | Ghamande S.; CHIA-CHI LIN ; Cho D.C.; Shapiro G.I.; Kwak E.L.; Silverman M.H.; Tseng Y.; Kuo M.-W.; Mach W.B.; Hsu S.-C.; Coleman T.; CHIH-HSIN YANG ; ANN-LII CHENG ; Ghalib M.H.; Chuadhary I.; Goel S. | Investigational New Drugs | 23 | 15 | |
2020 | Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts | Bang Y.-J.; Su W.-C.; Schuler M.; Nam D.-H.; Lim W.T.; Bauer T.M.; Azaro A.; Poon R.T.P.; Hong D.; CHIA-CHI LIN ; Akimov M.; Ghebremariam S.; Zhao S.; Giovannini M.; Ma B. | Cancer Science | 43 | 35 | |
2020 | A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies | Yamamoto N.; Ryoo B.-Y.; Keam B.; Kudo M.; CHIA-CHI LIN ; Kunieda F.; Ball H.A.; Moran D.; Komatsu K.; Takeda K.; Fukuda M.; Furuse J.; Morita S.; Doi T. | Investigational New Drugs | 15 | 14 | |
2022 | A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies | Shimizu T.; Kuboki Y.; CHIA-CHI LIN ; Yonemori K.; Yanai T.; Faller D.V.; Dobler L.; Gupta N.; Sedarati F.; Kim K.-P. | Targeted Oncology | 5 | 5 | |
2015 | Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: Pharmacokinetics and recommended phase 2 dose | Venkatakrishnan K.; Kim T.M.; CHIA-CHI LIN ; Thye L.S.; Chng W.J.; Ma B.; Chen M.H.; Zhou X.; Liu H.; Kelly V.; Kim W.S. | Investigational New Drugs | 26 | 27 | |
2012 | The phase 1 upgrade of the CMS pixel detector | RONG-SHYANG LU | Proceedings of Science | 0 | | |
2019 | A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas | CHIA-CHI LIN ; Arkenau H.-T.; Lu S.; Sachdev J.; de Castro Carpe?o J.; Mita M.; Dziadziuszko R.; Su W.-C.; Bobilev D.; Hughes L.; Chan J.; Zhang Z.-Y.; Weiss G.J. | British Journal of Cancer | 17 | 12 | |
2021 | Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors | Park K.; Tan D.S.W.; Su W.-C.; Cho B.C.; Kim S.-W.; Lee K.H.; Wang C.-C.; Seto T.; Huang D.C.-L.; Jung H.H.; Hsu M.-C.; Bogenrieder T.; CHIA-CHI LIN | JTO Clinical and Research Reports | 4 | 0 | |
2023 | A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George; Solomon, Benjamin; Lim, Darren Wan-Teck; RUEY-LONG HONG ; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre | Targeted oncology | 0 | | |
2018 | Phase 1�V3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22 | Oberguggenberger A.S.; Nagele E.; Inwald E.C.; Tomaszewski K.; Lanceley A.; Nordin A.; Creutzberg C.L.; Kuljanic K.; Kardamakis D.; Schmalz C.; Arraras J.; Costantini A.; Almont T.; Wei-Chu C.; Dehandschutter S.; Winters Z.; Greimel E.; the EORTC Quality of Life Group | Cancer Medicine | 28 | 23 | |
2010 | Phase 2 Results of Xl184 in a Cohort of Patients Pts with Advanced Non- Small Cell Lung Cancer Nsclc | YANG, CHIH-HSIN | EJC SUPPLEMENTS | | | |